We are live on ! Find out more
IGC icon

IGC Pharma
IGC

25 hedge funds and large institutions have $943K invested in IGC Pharma in 2024 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 2 increasing their positions, 6 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

36% more capital invested

Capital invested by funds: $692K → $943K (+$252K)

0% more funds holding

Funds holding: 25 → 25 (0)

0% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 6

0.31% less ownership

Funds ownership: 3.87% → 3.57% (-0.31%)

67% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 6

Holders
25
Holders Change
–
Holders Change %
0%
% of All Funds
0.36%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
2
Reduced
6
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$43.9K
2
XT
XTX Topco
Cayman Islands
+$9.09K
3
TSS
Two Sigma Securities
New York
+$5.1K
4
Jane Street
Jane Street
New York
+$4.53K
5
Fidelity Investments
Fidelity Investments
Massachusetts
+$806

Top Sellers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$21.5K
2
State Street
State Street
Massachusetts
-$20K
3
BCM
Bridgeway Capital Management
Texas
-$19.3K
4
VF
Virtu Financial
New York
-$17K
5
Group One Trading
Group One Trading
Illinois
-$7.19K
Name Holding Trade Value Shares
Change 		Change in
Stake
BlackRock
1
BlackRock
New York
$286K -$759 -2,444 -0.3%
Vanguard Group
2
Vanguard Group
Pennsylvania
$258K – – –
Geode Capital Management
3
Geode Capital Management
Massachusetts
$130K – – –
Renaissance Technologies
4
Renaissance Technologies
New York
$57K +$43.9K +141,303 New
State Street
5
State Street
Massachusetts
$47.9K -$20K -64,400 -35%
DP
6
Dearborn Partners
Illinois
$46.7K – – –
Northern Trust
7
Northern Trust
Illinois
$28.5K – – –
Goldman Sachs
8
Goldman Sachs
New York
$26.2K – – –
Group One Trading
9
Group One Trading
Illinois
$14.9K -$7.19K -23,153 -38%
Truist Financial
10
Truist Financial
North Carolina
$14.7K – – –
XT
11
XTX Topco
Cayman Islands
$11.7K +$9.09K +29,272 New
TSS
12
Two Sigma Securities
New York
$6.58K +$5.1K +16,437 New
Jane Street
13
Jane Street
New York
$5.83K +$4.53K +14,576 New
TRCT
14
Tower Research Capital (TRC)
New York
$5.46K -$3K -9,663 -41%
GWM
15
Geneos Wealth Management
Colorado
$1.2K – – –
Fidelity Investments
16
Fidelity Investments
Massachusetts
$1.1K +$806 +2,595 +1,663%
CTC
17
Central Trust Company
Missouri
$360 +$279 +900 New
Morgan Stanley
18
Morgan Stanley
New York
$344 -$267 -860 -50%
Osaic Holdings
19
Osaic Holdings
Arizona
$320 -$72 -232 -22%
CIBC Private Wealth Group
20
CIBC Private Wealth Group
Georgia
$312 +$203 +655 New
Wells Fargo
21
Wells Fargo
California
$152 +$2 +6 +2%
CJ
22
Caitlin John
Michigan
$80 – – –
DFA
23
DHJJ Financial Advisors
Illinois
$32 – – –
NA
24
NewEdge Advisors
Louisiana
$10 – – –
Toronto Dominion Bank
25
Toronto Dominion Bank
Ontario, Canada
$2 – – –
1
2

IGC Hedge Fund Activity: Q1 2024 in Review

25 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in IGC Pharma (IGC) for Q1 2024, worth a combined $943K — up 36% from $692K a quarter earlier.

Fund positioning in IGC was balanced in Q1 2024: 6 funds opened new positions, 6 closed out, 2 added to existing stakes and 6 trimmed.

The largest buyer was Renaissance Technologies, opening a new position worth an estimated $43.9K. The largest seller was Susquehanna International Group, exiting entirely with an estimated $21.5K sold.

  • 25 institutional investors held IGC Pharma (IGC) as of Q1 2024, unchanged from Q4 2023.
  • Funds reported $943K of IGC Pharma stock for Q1 2024, up 36% quarter-over-quarter.
  • 6 funds opened new IGC Pharma positions in Q1 2024 and 6 closed out, a net change of 0 holders.
  • The largest IGC Pharma buyer in Q1 2024 was Renaissance Technologies, an estimated $43.9K added.
  • The largest IGC Pharma seller in Q1 2024 was Susquehanna International Group, an estimated $21.5K sold.

Based on aggregated 13F filings for Q1 2024.